NCT06533293 Improving Neck Control in Children With Cerebral Palsy Using Robotics
| NCT ID | NCT06533293 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-03-06 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-03-06 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to characterize the head-neck motion of children with cerebral palsy and investigate how robotics can be used to improve the head-neck coordination of these children. Aim 1 is a cross-sectional study. In this single-session, kinematic and muscle activity data will be collected during the postural static, active-proactive, and reactive postural head tasks. Gross Motor Functional Classification System (GMFCS) levels will also be collected to categorize the sample into subgroups. Aim 2 is a prospective cohort quasi-experimental study. The data will be collected at baseline, across 12 intervention sessions, 1 week post-intervention, and 3 months follow-up. Functional assessments will be used to compare across the pre, mid, and post training. Participants will be assessed in Gross Motor Functional Measures (GMFM), Seated Posture and Reaching Control (SP\&R-co), and Canadian Occupational and Performance Measure (COPM). The primary outcomes will be SP\&R-co test and COPM pre- and post-intervention.
Eligibility Criteria
Inclusion Criteria: * CP, as medical diagnosis * GMFCS IV-V classification Exclusion Criteria: * severe cognitive deficits * uncontrolled epilepsy * severe dyskinesia * spinal cord malformations * severe vertebral column deformities (scoliosis \>40° and/or kyphosis \>45º) * blindness * chemo-denervation 3 months before study
Contact & Investigator
Sunil Agrawal
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT06533293 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 21 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06533293 currently recruiting?
Yes, NCT06533293 is actively recruiting participants. Contact the research team at sunil.agrawal@columbia.edu for enrollment information.
Where is the NCT06533293 trial being conducted?
This trial is being conducted at New York, United States, New York, United States.
Who is sponsoring the NCT06533293 clinical trial?
NCT06533293 is sponsored by Columbia University. The principal investigator is Sunil Agrawal at Columbia University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.